Dilated cardiomyopathy and heart transplantation
Fabián, J.; Bass, K.; Fischer, V.; Schreinerová, Z.; Schrameková, E.; Mizera, S.; Margitfalvi, P.
Bratislavske Lekarske Listy 98(5): 243-247
1997
ISSN/ISBN: 0006-9248 PMID: 9296828 Document Number: 472595
Authors compare selected demographic, clinical, methodological and laboratory parameters in 20 patients who underwent heart transplantation (HTx) because of dilated cardiomyopathy (DKMP) with those, who have had HTx because of progressive and otherwise unresolved coronary artery disease (KCH). Patients operated because of DKMP were younger than those who underwent HTx for KCH. Women were only in the group of DKMP. Otherwise there were no differences between these two groups. The global analysis showed, that the majority of patients after HTx were asymptomatic. However, high incidence of obesity, hyperlipoproteinemia, cytopoenia, renal and hepatal dysfunction were found. Finally the authors presented an overview of standard chronic therapy after HTx and proposed some approaches to undesirable habits and disorders which aggravated the prognosis of the patients after HTx.